Certified by Founder Lodge
BlackRock
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $120,000,000
137 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BlackRock is a global asset manager and technology provider. Our purpose is to help more and more people experience financial well-being. We help millions of people invest to build savings th
| Company | Date | Round | Raised |
|---|---|---|---|
 Underdog Fantasy |
July, 27 ,2022 | Series B | $35,000,000 |
 Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
 Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
 FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
 Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
 Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
 Versa Networks |
October, 27 ,2022 | Unknown | $120,000,000 |
 Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
 GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
| FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
 Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
 Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
 Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Underdog Fantasy |
July, 27 ,2022 | Series B | $35,000,000 |
 Prosimo.io |
June, 29 ,2022 | Series B | $30,000,000 |
| Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
| Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
| Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
 Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
 SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
| FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
| Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
| Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
| Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
 Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Prosimo.io |
June, 29 ,2022 | Series B | $30,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
| Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
| SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
 FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
 ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
| GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
 Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
 Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
 FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
| Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
| Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
| 10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
| FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
| Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
 Caresyntax |
August, 16 ,2024 | Series C | $180,000,000 |
| FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
 Tuio |
September, 26 ,2024 | Unknown | $16,700,000 |
| ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
 Tetrix |
September, 27 ,2024 | Seed | $5,000,000 |
| Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
 Double(US) |
December, 20 ,2024 | Seed | $3,900,000 |
| Groq |
August, 06 ,2024 | Series D | $640,000,000 |
| FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
| Caresyntax |
August, 16 ,2024 | Series C | $180,000,000 |
| Tuio |
September, 26 ,2024 | Unknown | $16,700,000 |
| Tetrix |
September, 27 ,2024 | Seed | $5,000,000 |
| Double(US) |
December, 20 ,2024 | Seed | $3,900,000 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
